Crossmark

HSP90 co-regulates the formation and nuclear distribution of the glycolytic output complex to promote resistance and poor prognosis in gastric cancer patients

Crossref DOI link: https://doi.org/10.1186/s12967-025-06196-w

Published Online: 2025-02-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shen, Gaigai

Liu, Shiya

Cao, Yuanting

Chen, Zihao

Wang, Guanghui

Yu, Long

Sun, Lixin

Ran, Yuliang
Funding

Funding for this research was provided by:

National Key Research and Development Program of China (2022YFC2409902)

National Natural Science Foundation of China (82073278)

CAMS Innovation Fund for Medical Sciences (2021-I2M-1-067)

The Independent Issue of State Key Laboratory of Molecular Oncology (SKLMO-2023-17)
License Information

Text and Data Mining valid from 2025-02-10

Version of Record valid from 2025-02-10
More Information

Article History

Received: 5 December 2024

Accepted: 29 January 2025

First Online: 10 February 2025

Declarations

:

: Not applicable, this study does not include any experiments involving animal and patients.

: Not applicable, this study does not contain any individual person’s data in any form.

: The authors have declared that no competing interest exists.

Document is current

Any future updates will be listed below